David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Insulet
PODD
$10.3B
| $81.4M | 0.11% |
855,676
-529,853
| -38% | -$45.4M |
|
227
Viatris
VTRS
$18.7B
| $81.3M | 0.11% |
2,868,398
-3,858,578
| -57% | -$113M |
|
|
GRA
228
DELISTED
W.R. Grace & Co.
GRA
| $81M | 0.1% |
1,037,892
+105,791
| +11% | +$7.8M |
|
229
Expedia Group
EXPE
$38.6B
| $80.8M | 0.1% |
678,997
-83,932
| -11% | -$10.2M |
|
|
EA
230
PUT
DELISTED
Electronic Arts
EA
| $80.6M | 0.1% |
792,900
-133,000
| -14% | -$12.6M |
|
231
CALL
Intel
INTC
$476B
| $80.4M | 0.1% |
1,497,000
-811,900
| -35% | -$41.2M |
|
232
Kraft Heinz
KHC
$30.3B
| $80.1M | 0.1% |
2,453,546
-2,123,745
| -46% | -$86.5M |
|
233
CALL
Wells Fargo
WFC
$254B
| $79.8M | 0.1% |
1,651,800
+149,000
| +10% | +$7.33M |
|
234
CALL
Goldman Sachs
GS
$303B
| $79.4M | 0.1% |
413,400
+277,300
| +204% | +$53.5M |
|
235
PUT
General Motors
GM
$77.2B
| $78.4M | 0.1% |
2,114,000
-4,915,900
| -70% | -$187M |
|
236
CVS Health
CVS
$119B
| $78.3M | 0.1% |
1,452,050
-161,590
| -10% | -$9.97M |
|
237
PUT
Procter & Gamble
PG
$336B
| $77.9M | 0.1% |
748,900
-49,600
| -6% | -$4.83M |
|
238
PUT
Halliburton
HAL
$29.4B
| $77.8M | 0.1% |
2,657,000
+1,036,900
| +64% | +$31.3M |
|
|
TWTR
239
PUT
DELISTED
Twitter, Inc.
TWTR
| $77.8M | 0.1% |
2,367,000
-1,795,600
| -43% | -$56.9M |
|
240
Quanta Services
PWR
$96.1B
| $77.5M | 0.1% |
2,054,417
+487,889
| +31% | +$17M |
|
241
CALL
Baidu
BIDU
$31.6B
| $77.4M | 0.1% |
469,700
+379,500
| +421% | +$63.5M |
|
242
Regeneron Pharmaceuticals
REGN
$85.9B
| $77.4M | 0.1% |
188,420
-170,246
| -47% | -$70.1M |
|
243
Seagate
STX
$193B
| $77.4M | 0.1% |
1,615,467
-184,539
| -10% | -$8.19M |
|
|
HTZ
244
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $76.8M | 0.1% |
5,092,100
+120,689
| +2% | +$1.76M |
|
245
KLA
KLAC
$240B
| $76.8M | 0.1% |
6,430,430
-1,571,020
| -20% | -$16.9M |
|
|
HBI
246
DELISTED
Hanesbrands
HBI
| $76.7M | 0.1% |
+4,287,777
| New | +$71.2M |
|
|
JNPR
247
DELISTED
Juniper Networks
JNPR
| $76.6M | 0.1% |
2,895,389
+1,068,311
| +58% | +$28.8M |
|
248
CALL
GE Aerospace
GE
$361B
| $76M | 0.1% |
1,526,323
-338,928
| -18% | -$16M |
|
249
PUT
Applied Materials
AMAT
$391B
| $75.5M | 0.1% |
1,904,100
+1,300
| +0.1% | +$49.4K |
|
250
M&T Bank
MTB
$34.7B
| $75.3M | 0.1% |
479,868
-384,875
| -45% | -$63.2M |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.